NYSE: FNA

Paragon 28 Inc Stock Forecast, Predictions & Price Target

The consensus among 3 Wall Street analysts covering (NYSE: FNA) stock is to Strong Buy FNA stock.

Out of 3 analysts, 2 (66.67%) are recommending FNA as a Strong Buy, 1 (33.33%) are recommending FNA as a Buy, 0 (0%) are recommending FNA as a Hold, 0 (0%) are recommending FNA as a Sell, and 0 (0%) are recommending FNA as a Strong Sell.

If you're new to stock investing, here's how to buy Paragon 28 stock.

(NYSE: FNA) Paragon 28's forecast annual revenue growth rate of 18.3% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.7%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.39%.

Paragon 28's revenue in 2024 is $216,389,000.On average, 2 Wall Street analysts forecast FNA's revenue for 2024 to be $21,047,248,335, with the lowest FNA revenue forecast at $20,964,411,243, and the highest FNA revenue forecast at $21,130,085,427. On average, 2 Wall Street analysts forecast FNA's revenue for 2025 to be $24,866,866,647, with the lowest FNA revenue forecast at $24,841,187,149, and the highest FNA revenue forecast at $24,892,546,146.

In 2026, FNA is forecast to generate $29,458,526,657 in revenue, with the lowest revenue forecast at $29,458,526,657 and the highest revenue forecast at $29,458,526,657.

According to 3 Wall Street analysts that have issued a 1 year FNA price target, the average FNA price target is $18.00, with the highest FNA stock price forecast at $18.00 and the lowest FNA stock price forecast at $18.00.

On average, Wall Street analysts predict that Paragon 28's share price could reach $18.00 by Apr 5, 2025. The average Paragon 28 stock price prediction forecasts a potential upside of 86.53% from the current FNA share price of $9.65.

(NYSE: FNA) forecast ROE is N/A, which is considered weak.